Linking Lungs and Heart
CHEST · 2026-08 · 170 (2) · 383-393
DOI: 10.1016/j.chest.2026.03.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2026-08. Verfasst von Jessica González und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Institute of Lleida-Dr. Pifarré Foundation, Institut de Recerca Biomèdica de Lleida, Lleida, Spain; Departament of Pulmonology, A…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Vascular Calcification, Pulmonary Emphysema. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NewYork-Presbyterian Hospital, American Cancer Society Inc, Flight Attendant Medical Research Institute Inc.
Abstract (Originalsprache)
BACKGROUND Low-dose CT (LDCT) imaging of the chest for lung cancer screening provides an opportunity to evaluate smoking-related comorbidities such as emphysema and coronary artery calcification (CAC). Although cross-sectional associations exist, the long-term relationship between emphysema subtypes and CAC progression remains undefined. RESEARCH QUESTION Is any emphysema subtype associated with long-term CAC progression? STUDY DESIGN AND METHODS All total 256 participants with ≥ 15 years of follow-up were included from a prospective cohort of 9,047 asymptomatic, high-risk individuals enrolled in the Mount Sinai Early Lung and Cardiac Action Program (New York, June 2000-August 2004). Emphysema and its 2 subtypes-centrilobular (CLE) emphysema and paraseptal emphysema (PSE)-were assessed visually and graded using an enhanced Fleischner Society classification. CAC was scored using a validated ordinal method. Progression was defined as any increase in total score from baseline to follow-up. Logistic regression was used to identify predictors of CAC progression, including CLE and PSE progression, adjusted for age, smoking status, and pack-years of smoking. RESULTS Among 256 participants (50% female and 50% male; median age, 58 years [interquartile range (IQR), 52-63]), most participants (69.1%) had a history of former smoking at enrollment, with a median of 31.1 pack-years of smoking (IQR, 21-49 pack-years). Progression of CAC and emphysema was observed in 182 participants (71.7%) and 145 participants (56.6%), respectively, over a median follow-up of 18.3 years (IQR, 16.7-20.5 years). Participants with CAC progression showed significantly higher rates of any emphysema both at baseline (70.9% vs 54.2%; P = .011) and at follow-up (75.8% vs 56.9%; P = .003). This group also showed higher median CLE scores at baseline (2.00 vs 0.00; P < .001) and follow-up (5.00 vs 0.00; P < .001). In multivariable logistic regression adjusted for age, smoking status, and pack-years of smoking, CLE progression was associated strongly with CAC progression (OR, 3.32; 95% CI, 1.75-6.63; P < .001). In contrast, PSE showed no significant association with CAC progression (OR, 1.17; 95% CI, 0.32-5.64; P = .83). INTERPRETATION Our results show that in this long-term screening cohort, progression of CLE-but not PSE-was linked to CAC progression, highlighting the value of detailed emphysema assessment in screening programs and supporting CLE as a systemic disorder with prognostic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Research Institute of Lleida-Dr. Pifarré Foundation, Institut de Recerca Biomèdica de Lleida, Lleida, Spain; Departament of Pulmonology, Arnau de Vilanova and Santa Maria University Hospital, Lleida, Spain; C…
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY; Departments of Medicine, Radiology, and Research, Phoenix Veterans Affairs Health Care System, Ph…
Förderung
- NewYork-Presbyterian Hospital
- American Cancer Society Inc
- Flight Attendant Medical Research Institute Inc
- New York State Foundation for Science Technology and Innovation
- US Department of Energy
- The Starr Foundation
- Weill Cornell Medical College
- Annenberg Foundation
Zitieren
APA
González, J., Yip, R., Zhang, J., Jirapatnakul, A., Yankelevitz, D. F., & Henschke, C. I. (2026). Linking Lungs and Heart. CHEST, 170(2), 383-393. https://doi.org/10.1016/j.chest.2026.03.022
Vancouver
González J, Yip R, Zhang J, Jirapatnakul A, Yankelevitz DF, Henschke CI. Linking Lungs and Heart. CHEST. 2026;170(2):383-393. doi:10.1016/j.chest.2026.03.022
BibTeX
@article{Gonzlez2026,
author = {González, Jessica and Yip, Rowena and Zhang, Jiafang and Jirapatnakul, Artit and Yankelevitz, David F and Henschke, Claudia I},
title = {Linking Lungs and Heart},
journal = {CHEST},
year = {2026},
volume = {170},
number = {2},
pages = {383--393},
doi = {10.1016/j.chest.2026.03.022}
}
EUVIMED